Docplix Secures Bridge Funding Led by Inflection Point Ventures

Per the startup, the recent funding will be used for product development, AI integration, and market expansion.

Lucknow-based healthtech startup Docplix has raised INR 1.2 Cr in a bridge funding round led by Inflection Point Ventures (IPV), a Gurugram-based angel investment firm. 

The recent infusion of funds will be used for product development, AI integration, and market expansion. 

According to the startup, it aims to enhance its electronic health record (EHR) system with advanced AI capabilities to improve decision support and patient care. 

Additionally, the company intends to expand its market reach, bringing its innovative healthcare solutions to larger clinics and hospitals.

In an exclusive conversation with DHN, Aayush Garg, cofounder and CTO of Docplix, said, 'Our goal is to improve clinic efficiency and empower healthcare professionals with the tools they need to provide better care. The recent funding will enable us to accelerate product development and expand our reach, ensuring that even the most remote areas can access top-notch healthcare solutions.”

Founded in 2021, Docplix is building an ecosystem that allows seamless data exchange between doctors and patients. It also provides technology products for clinics and hospitals that let them deliver an exceptional visitor experience to patients. 

DocPlix Rx is an electronic medical records system for clinics and hospitals that helps doctors grow their practice and deliver smart patient care.

It claims to have boarded over 2000 doctors, with specialties including endocrinologists, cardiovascular surgeons, dermatologists, oncologists, dentists, and others. 

Further, the company is eying to onboard 5000 doctors through its speech-to-text EHR in the next 10 months and sell 5000 licenses of its medical algorithms-based chatbot, Panini.

Digitizing Health Records

Operating in the healthcare industry, Docplix focuses on digitizing health records for 1.4 billion Indians. The startup has developed an ABDM-compliant EHR system that ensures secure and interoperable patient data management. 

Its integrated decision support system (DSS) helps healthcare professionals make informed decisions through data analytics. The startup’s innovative visualization tools make patient data easy to understand, enhancing patient care and clinic efficiency.

Sharing insights, Dr Varun Garg, cofounder & CEO of Docplix, said, “Our goal is to become the leading EHR provider in India, leveraging advanced technologies like AI and data analytics to transform healthcare delivery. With a strong foundation and the support of IPV, we are poised to scale globally, starting with the USA, while continuously innovating to meet the evolving needs of healthcare professionals and patients." 

Sharp Rise of the EHR Market

In 2022, the Indian EHR market was valued at approximately $414 million and projected to reach $900 million by 2030. Globally, the EHR market was valued at $25 billion in 2022 and is expected to grow to $40 billion by 2032. 

Meanwhile, the Indian Lifestyle & Wellness market stood at $1,300 billion in 2024, while the global market reached $5,546 billion in 2023 and is forecasted to reach $9,246 billion by 2033.

Vinay Bansal, founder & CEO of Inflection Point Ventures, said, “The government’s initiative Ayushman Bharat Digital Mission to build a health ID repository of all citizens for easy exchange of information between the doctors and patients is not a small feat.’’

He further noted that Docplix aims to help citizens and healthcare providers integrate into a tech-enabled healthcare system that can substantially improve patient diagnosis and treatment. 

“At IPV, we have always invested in companies using tech for good to bring real-life change in the users' lives. Docplix's powerful platform, wellness programs, and addressing access to healthcare in tier 2 and 3 towns drove our decision to invest in the startup,” founder Bansal added.

DocPlix’s Funding Spree

Previously, in 2023, DocPlix secured INR 5 Cr in its Pre-Series A round. The funding was led by Eris Lifesciences, a prominent player in the healthcare industry, with participation from other angel investors.

Notably, in February 2022, the startup raised INR 1.2 Cr in a Seed Round with the participation of angel investors, laying the groundwork for its subsequent growth and development. 

The funds from these rounds are earmarked for scaling up operations, conducting research and development, and expanding the company's footprint in the healthcare sector.